Huang, Shiya
Hu, Min
Ng, Ernest Hung Yu
Stener-Victorin, Elisabet
Zheng, Yanhua
Wen, Qidan
Wang, Cong
Lai, Maohua
Li, Juan
Gao, Xingcheng
Wang, Xinhua
Hu, Zhenxing
Xia, Tian
Hu, Rongkui
Liu, Jianping
Wen, Xiaohui
Li, Shuna
Quan, Kewei
Liang, Xingyan
Shang, Hongcai
Ma, Hongxia http://orcid.org/0000-0002-4477-613X
Qiao, Jie
Funding for this research was provided by:
High-level University Construction Innovation Team Training Foundation in Guangzhou Medical University
Guangdong Province High-level Hospital Construction Foundation
Article History
Received: 29 August 2019
Accepted: 10 February 2020
First Online: 4 March 2020
Ethics approval and consent to participate
: Central ethical approval has been granted by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University (reference approval no. 2018019), and we will not begin recruiting at other centers in the trial until local ethical approval has been obtained. Any protocol modifications will be approved by this ethics committee before implementation. All participants and their husbands will sign the informed consent form prior to participation, and they will be made fully aware that they are free to withdraw from the study at any time. All AEs and SAEs during the treatment period will be documented. This study is referred to as the Personalized PCOS Acupuncture clinical trial (PPCOSAct). It has been registered with ExternalRef removed (NCT03625531; ExternalRef removed) and the Chinese Clinical Trials Registry (ChiCTR1800017304; ExternalRef removed).
: Decisions concerning publication will be determined by consensus (majority vote) of the collaborating PIs (or their designates). All authorship for final publication is expected to meet the criteria set forth by the International Committee of Medical Journal Editors for uniform requirements for manuscripts submitted to biomedical journals (ExternalRef removed; updated October 2008).
: The authors declare that they have no competing interests.